US Patent No: 5,360,894

Number of patents in Portfolio can not be more than 2000

C/EBP2 gene and recombinant C/EBP2

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to a gene which codes for the IL-6 gene expression inducing nuclear factor C/EBP2 capable of binding sequence-specifically to the palindrome structure SEQ ID NO:2 located in the transcriptional regulatory region of the IL-6 gene; an expression plasmid with the C/EBP2 gene incorporated therein; an transformant harboring the expression plasmid; a recombinant C/EBP2 obtained by expressing the C/EBP2 gene; and a method of producing the recombinant C/EBP2.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
TADAMITSU KISHIMOTOTOKYO13

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akira, Shizuo Osaka, JP 33 45
Hirano, Toshio Osaka-shi, Osaka-fu, JP 40 121
Isshiki, Hiroshi Osaka, JP 6 22
Kinoshita, Shigemi Ibaragi, JP 2 9
Kishimoto, Tadamitsu Tondabayashi, JP 54 503
Shimamoto, Takuya Minoo, JP 2 9
Tanabe, Osamu - 17 81

Cited Art Landscape

  • No Cited Art to Display

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
ISIS PHARMACEUTICALS, INC. (1)
6,271,030 Antisense inhibition of C/EBP beta expression 2 2000
 
SALUTRIA PHARMACEUTICALS LLC (1)
7,071,158 Antioxidant enhancement of therapy for hyperproliferative conditions 1 2001
 
VANDERBILT UNIVERSITY (1)
7,074,399 Treatment of inflammation with p20 0 2001

Full Text

 
loading....